Drug research

ML-004 (IR)/(ER) tablet

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)NCT05081245	MapLight Therapeutics	Phase 2	Completed	2026-03-10Actual
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)NCT05889273	MapLight Therapeutics	Phase 2	Active not recruiting	2027-11Estimated

MapLight TherapeuticsCompletedPrimary completion: 2026-03-10 · Actual

Trial details

MapLight TherapeuticsActive not recruitingPrimary completion: 2027-11 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.